Clinical Trials
4 trialsNCT02834013 2026-06-03
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT04188535 2025-08-26
RELAY
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT06582849 2025-08-26
EARN
Washington University School of Medicine
Phase NA Completed